Clofazimine is a broad-spectrum coronavirus inhibitor that antagonizes SARS-CoV-2 replication in primary human cell culture and hamsters

COVID-19 pandemic is the third zoonotic coronavirus (CoV) outbreak of the century after severe acute respiratory syndrome (SARS) in 2003 and Middle East respiratory syndrome (MERS) since 2012. Treatment options for CoVs are largely lacking. Here, we show that clofazimine, an anti-leprosy drug with a...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Res Sq
Main Authors: Yuan, Shuofeng, Yin, Xin, Meng, XiangZhi, Chan, Jasper, Ye, Zi-Wei, Riva, Laura, Pache, Lars, Chan, Chris Chun-Yiu, Lai, Pok-Man, Chan, Chris, Poon, Vincent, Matsunaga, Naoko, Pu, Yuan, Yuen, Chun-Kit, Cao, Jianli, Liang, Ronghui, Tang, Kaiming, Sheng, Li, Du, Yushen, Xu, Wan, Sze, Kong-Hung, Zhang, Jinxia, Chu, Hin, Kok, Kin-Hang, To, Kelvin, Jin, Dong-Yan, Sun, Ren, Chanda, Sumit, Yuen, Kwok-Yung
Formato: Artigo
Idioma:Inglês
Publicado: American Journal Experts 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7553155/
https://ncbi.nlm.nih.gov/pubmed/33052331
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-86169/v1
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares